Lung Cancer Clinical Trial
National Comprehensive Cancer Network (NCCN) Decision Support Tool for Patients With NSCLC
Summary
This study involves the evaluation of a decision support tool, based on the patient version of the NCCN guidelines, for the non-small cell lung cancer patient population.
Full Description
This study involves the evaluation of a decision support tool, based on the patient version of the NCCN guidelines, for the non-small cell lung cancer patient population. The decision support tool is offered by a trained coordinator to the patient and then utilized during an initial consultation. Patients complete forms before and after the visit indicating their level of decisional conflict, satisfaction, and satisfaction with decision. Pre-determined indices of quality of care were also collected by the study team.
Eligibility Criteria
Inclusion Criteria:
Over age of 18
Able to provide informed consent
Able to use a web-based interface
Histologically proven or clinically apparent diagnosis of non-small cell lung cancer
Newly diagnosed, with new primary occurrence of NSCLC, or diagnosed with a new recurrence or new progression of existing disease, and not yet treated for the new problem
Being seen in consultation at thoracic oncology clinics
Exclusion Criteria:
Unable to fill out questionnaires
Already treated for the current diagnosis of a new primary occurrence of NSCLC, or already treated for the new recurrence or new progression of existing disease
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
San Francisco California, 94143, United States
How clear is this clinincal trial information?
